Navigation Links
Accumetrics, Inc. Announces Distribution Channels in Israel and Cyprus

SAN DIEGO, June 9 /PRNewswire/ -- Accumetrics, Inc. announces today it has signed new distribution agreements for its VerifyNow(R) System in both Israel and Cyprus. Medtechnica, Ltd. will oversee distribution of all VerifyNow products in Israel, while Z.S. Curemed, Ltd. will be the sole distribution channel in Cyprus. These distribution agreements continue to expand Accumetrics' reach in both scope and geography, and add to the growing numbers of countries outside of the United States and Europe where physicians have access to the VerifyNow System.

The VerifyNow System assesses response to antiplatelet therapies, such as aspirin, Plavix(R) and GP IIb/IIIa inhibitors. As response to these drugs varies, the tests help physicians ensure their patients on antiplatelet medications are receiving the optimal benefit.

"We're extremely excited to see distribution of our VerifyNow System reach Israel and Cyprus. We have chosen these partners based on their demonstrated expertise and knowledge of our markets in their respective territories," said Timothy I. Still, President and CEO of Accumetrics. "These partnerships continue to emphasize our focus on expanding our global distribution channels, and support our vision of providing physicians worldwide access to critical information for managing their cardiovascular patients on antiplatelet therapies."

About Accumetrics (

Accumetrics is committed to advancing medical understanding of platelet function and enhancing quality of care for patients receiving antiplatelet therapies by providing industry-leading and widely accessible diagnostic tests for rapid platelet function assessment.

Accumetrics' VerifyNow System is the first rapid and easy to use platform for measuring an individual's response to multiple antiplatelet agents. Addressing every major antiplatelet drug, including EC-cleared product for prasugrel and FDA-cleared products for aspirin, Plavix, ReoPro(R), and Integrilin(R), the VerifyNow System provides a valuable tool to help physicians make informed treatment decisions.

The Accumetrics logo and VerifyNow are registered trademarks of Accumetrics, Inc., ReoPro is a registered trademark of Centocor, Inc. Integrilin is a registered trademark of Millennium Pharmaceuticals. Plavix is a registered trademark of sanofi-aventis.

About Medtechnica, Ltd.

Founded in 1958, Medtechnica, Ltd. has become one of the largest medical equipment suppliers in Israel. Medtechnica is the sole distributor, in Israel, of leading international manufacturers of medical equipment, including Phillips Medical Systems, Olympus Medical, Maquet, 3M Medical and among others.

About Z.S. Curemed, Ltd.

Established in 2001 in Cyprus, Curemed has grown to become one of the leading companies in the sectors of Interventional Cardiology and Intensive Care. Curemed focuses on promotion, sales and support of innovative Interventional Cardiology and Intensive Care devices to Public and Private Hospitals in Cyprus. Curemed conforms to EN ISO 9001: 2008.

    Jules Abraham
    Lippert/Heilshorn & Associates

    Timothy I. Still
    President and CEO

SOURCE Accumetrics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Accumetrics, Inc. Announces 1000th Patient Enrolled in GRAVITAS Trial
2. Accumetrics, Inc. Announces United Kingdom Distribution Agreement With ELITech UK Limited
3. Gregory J. Tibbitts Appointed Chief Financial Officer at Accumetrics, Inc.
4. Ad de Waard Appointed Vice President of International Sales and Marketing at Accumetrics, Inc.
5. Accumetrics, Inc. Appoints William Dippel as Executive Vice President of Operations and R&D
6. Quark Pharmaceuticals Announces the Presentation of Data Indicating Potential Utility of QPI-1002 in Chronic Kidney Disease at the RNA Interference Summit
7. Morphotek(R), Inc. Announces FDA Acceptance of Investigational New Drug Application for MORAb-004, a Monoclonal Antibody for the Treatment of Solid Tumors
8. Abbott Announces New EAS(R) Myoplex(R) Strength Formula Nutrition Shake and Debuts Bottle Packaging
9. Life Spine Announces Appointment of Todd Fanning as Vice President of Sales
10. CareFusion Announces Board of Directors, Progress on Alaris Consent Decree
11. ThinIdentity(TM) Announces Two New Board Members
Post Your Comments:
(Date:6/25/2016)... Washington, D.C. (PRWEB) , ... June 25, 2016 ... ... will discuss health policy issues and applications at AcademyHealth’s Annual Research Meeting June ... share their work on several important health care topics including advance care planning, ...
(Date:6/25/2016)... ... , ... First Choice Emergency Room , the largest network of independent ... Director of its new Mesquite-Samuell Farm facility. , “We are pleased to announce ... Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. , ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of moderation, whether ... latter, setting the bar too high can result in disappointment, perhaps even self-loathing. However, ... their goal. , Research from reveals that behind the tendency ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... Marcy was in a crisis. Her ... would lash out at his family verbally and physically. , “When something upset him, he ... he would use it. He would throw rocks at my other children and say he ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Comfort Keepers® of ... Cancer Society and the Road To Recovery® program to drive cancer patients to and ... other adults to ensure the highest quality of life and ongoing independence. Getting ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Research and Markets has announced the ... Tests" report to their offering. ... The World Market for Companion Diagnostics covers the ... analysis in the report includes the following: ... Kits) by Region (N. America, EU, ROW), 2015-2020 , ...
(Date:6/24/2016)... June 24, 2016   Pulmatrix, Inc ., (NASDAQ: ... innovative inhaled drugs, announced today that it was added ... reconstituted its comprehensive set of U.S. and global ... is an important milestone for Pulmatrix," said Chief Executive ... awareness of our progress in developing drugs for crucial ...
(Date:6/24/2016)... KNOXVILLE, Tenn. , June 24, 2016 /PRNewswire/ ... market providing less invasive and more durable cerebrospinal ... million in funding.  The Series-A funding is led ... the Lighthouse Fund, and other private investors.  Arkis, ... less-invasive neurosurgical instrumentation and the market release of ...
Breaking Medicine Technology: